Target intelligence / Profile preview

Myoglobin (MB) (MB)

Target
MB
Molecular classification
Globin superfamily, Hemoprotein, Oxygen-binding protein
01

Overview

Myoglobin is a monomeric, heme-containing protein primarily located in the cardiac and skeletal muscle of vertebrates [1, 8]. Its primary biological role is to store oxygen and facilitate its diffusion to mitochondria, thereby supporting aerobic metabolism during muscle contraction [8, 12]. Beyond oxygen transport, myoglobin acts as a scavenger of nitric oxide (NO) and reactive oxygen species (ROS), and it can function as a nitrite reductase under hypoxic conditions to produce NO and regulate vasodilation [11, 17]. Clinically, myoglobin is a critical biomarker; its release into the bloodstream following muscle injury (rhabdomyolysis) or myocardial infarction serves as an early indicator of tissue damage [2, 9]. However, elevated systemic myoglobin is a potent protoxin that can cause acute kidney injury through the induction of oxidative stress and direct toxic effects on renal tubular cells [8, 16]. While not a traditional therapeutic target for drugs, its levels are monitored to assess the safety and efficacy of treatments for muscle and heart conditions [7, 9].

Other names
MBMyohemoglobinMyohaemoglobin
02

Mechanism of action

Not applicable; myoglobin is primarily a biomarker and protoxin rather than a therapeutic drug target.

03

Biological functions

Oxygen storageFacilitated oxygen diffusionNitric oxide scavengingNitrite reductase activityReactive oxygen species scavenging
04

Disease associations

RhabdomyolysisMyocardial infarctionAcute kidney injuryCardiovascular disease
05

Safety considerations

NephrotoxicityAcute tubular necrosisOxidative stressLipid peroxidation
06

Biomarkers

Serum myoglobinUrinary myoglobin

Beyond the preview

Go deeper on Myoglobin (MB) (MB).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Myoglobin (MB) (MB).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call